A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children

NHS Greater Glasgow Yorkhill Division

Status and phase

Unknown

Phase 4

Conditions

Epistaxis

Treatments

Procedure: Nasal Cautery

Study type

Interventional

Funder types

Other

Identifiers

NCT00390663

05/EN/03

Details and patient eligibility

About

To determine whether the selective application of a combined treatment regimen of silver nitrate cautery and 4 weeks of Naseptin cream is superior to naseptin treatment alone in the management of recurrent paediatric epistaxis.

Sex

All

Ages

1 to 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Children aged 1 - 14
History of repeated epistaxis with at least 1 episode in the previous 4 weeks prior to attending the ENT clinic.
Presence of prominent vessels on the anterior nasal septum on the side that reportedly bleeds (or on at least one side if bleeding is reported to be bilateral)

Exclusion criteria

No prominent vessels on examination (these children will be randomised but will be prescribed Naseptin alone and followed up in the same way as the children in the trial, for completeness of data)
Known bleeding disorders.
Allergy to peanuts, neomycin or chlorhexidine
Other causes of nose bleeding eg tumour.